131 related articles for article (PubMed ID: 28431782)
1. Preface to Volume 42.
Profiles Drug Subst Excip Relat Methodol; 2017; 42():xi. PubMed ID: 28431782
[No Abstract] [Full Text] [Related]
2. Preface to Volume 40.
Brittain HG
Profiles Drug Subst Excip Relat Methodol; 2015; 40():ix-xii. PubMed ID: 26051691
[No Abstract] [Full Text] [Related]
3. Preface to Volume 43.
Brittain HG
Profiles Drug Subst Excip Relat Methodol; 2018; 43():ix. PubMed ID: 29678265
[No Abstract] [Full Text] [Related]
4. The comprehensive profiling of drug substances and pharmaceutical excipients. Preface.
Brittain HG
Profiles Drug Subst Excip Relat Methodol; 2013; 38():xi. PubMed ID: 23668412
[No Abstract] [Full Text] [Related]
5. Challenges of pediatric formulations: a FDA science perspective.
Gupta A; Khan MA
Int J Pharm; 2013 Nov; 457(1):346-8. PubMed ID: 24216242
[No Abstract] [Full Text] [Related]
6. Preface to volume 39.
Brittain HG
Profiles Drug Subst Excip Relat Methodol; 2014; 39():ix. PubMed ID: 24794913
[No Abstract] [Full Text] [Related]
7. A new paradigm for improving oral absorption of drugs in discovery: role of physicochemical properties, different excipients and the pharmaceutical scientist.
Wilson AG; Nouraldeen A; Gopinathan S
Future Med Chem; 2010 Jan; 2(1):1-5. PubMed ID: 21426039
[No Abstract] [Full Text] [Related]
8. Carrageenan as an efficient drug release modifier for ethylcellulose-coated pharmaceutical dosage forms.
Siepmann F; Muschert S; Zach S; Leclercq B; Carlin B; Siepmann J
Biomacromolecules; 2007 Dec; 8(12):3984-91. PubMed ID: 18039003
[No Abstract] [Full Text] [Related]
9. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
10. In vitro hemolysis: guidance for the pharmaceutical scientist.
Amin K; Dannenfelser RM
J Pharm Sci; 2006 Jun; 95(6):1173-6. PubMed ID: 16639718
[TBL] [Abstract][Full Text] [Related]
11. Stable isotope-labeled excipients for drug product identification and counterfeit detection.
Felton LA; Shah PP; Sharp Z; Atudorei V; Timmins GS
Drug Dev Ind Pharm; 2011 Jan; 37(1):88-92. PubMed ID: 20560792
[TBL] [Abstract][Full Text] [Related]
12. ¹³C solid-state NMR analysis of the most common pharmaceutical excipients used in solid drug formulations, Part I: Chemical shifts assignment.
Pisklak DM; Zielińska-Pisklak MA; Szeleszczuk Ł; Wawer I
J Pharm Biomed Anal; 2016 Apr; 122():81-9. PubMed ID: 26845204
[TBL] [Abstract][Full Text] [Related]
13. Application of instrumented nanoindentation in preformulation studies of pharmaceutical active ingredients and excipients.
Egart M; Janković B; Srčič S
Acta Pharm; 2016 Sep; 66(3):303-30. PubMed ID: 27383883
[TBL] [Abstract][Full Text] [Related]
14. Electrostatic powder coating: Principles and pharmaceutical applications.
Prasad LK; McGinity JW; Williams RO
Int J Pharm; 2016 May; 505(1-2):289-302. PubMed ID: 27085644
[TBL] [Abstract][Full Text] [Related]
15. Influence of size and density of particles on flow properties of granules.
Czarnecki W; Szumiło M; Wasik D
Acta Pol Pharm; 2009; 66(5):553-61. PubMed ID: 19894652
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting drug release from hydroxypropyl methylcellulose matrix systems in the light of classical and percolation theories.
Caraballo I
Expert Opin Drug Deliv; 2010 Nov; 7(11):1291-301. PubMed ID: 20977292
[TBL] [Abstract][Full Text] [Related]
17. Solubilisation of drugs within liposomal bilayers: alternatives to cholesterol as a membrane stabilising agent.
Ali MH; Kirby DJ; Mohammed AR; Perrie Y
J Pharm Pharmacol; 2010 Nov; 62(11):1646-55. PubMed ID: 21039548
[TBL] [Abstract][Full Text] [Related]
18. Roll compaction/dry granulation: pharmaceutical applications.
Kleinebudde P
Eur J Pharm Biopharm; 2004 Sep; 58(2):317-26. PubMed ID: 15296958
[TBL] [Abstract][Full Text] [Related]
19. [On the coloring matter used in the coating of medicaments].
DORLET C
J Pharm Belg; 1959; 14():276-9. PubMed ID: 13817670
[No Abstract] [Full Text] [Related]
20. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
